Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market
Holding ALLO?
Track your performance easily

Allogene Therapeutics (ALLO) Balance Sheet

1,302 Followers

Allogene Therapeutics Balance Sheet

Allogene Therapeutics's total assets for Q3 2024 were $589.12M, a decrease of -8.93% from the previous quarter. ALLO total liabilities were $125.37M for the fiscal quarter, a -4.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 642.84M$ 821.58M$ 1.04B$ 1.23B$ 717.80M
Total Liabilities
$ 130.60M$ 154.70M$ 122.23M$ 148.21M$ 88.78M
Total Equity Gross Minority
$ 512.23M$ 666.88M$ 916.41M$ 1.08B$ 629.02M
Total Capitalization
$ 600.58M$ 762.00M$ 986.34M$ 1.13B$ 629.02M
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

Allogene Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis